Influence of gold nanoparticles on the kinetics of α-synuclein aggregation

α-synuclein (AS) is a small (140 amino acids), abundant presynaptic protein, which lacks a unique secondary structure in aqueous solution. Amyloid aggregates of AS in dopaminergic neurons of the midbrain are the hallmark of Parkinson's disease (PD). The process of aggregation involves a series...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Álvarez, Y.D
Otros Autores: Fauerbach, J.A, Pellegrotti, J.V, Jovin, T.M, Jares-Erijman, E.A, Stefani, F.D
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2013
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 13397caa a22014177a 4500
001 PAPER-11059
003 AR-BaUEN
005 20230518204110.0
008 190411s2013 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-84890413185 
024 7 |2 cas  |a alpha synuclein, 154040-18-3; amyloid, 11061-24-8; gold, 7440-57-5; Amyloid; Gold, 7440-57-5; alpha-Synuclein 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a NALEF 
100 1 |a Álvarez, Y.D. 
245 1 0 |a Influence of gold nanoparticles on the kinetics of α-synuclein aggregation 
260 |c 2013 
270 1 0 |m Stefani, F.D.; Departamento de Física, Facultad de Ciencias Exactas y Naturales (FCEN), Universidad de Buenos Aires (UBA), Buenos Aires, Argentina; email: fernando.stefani@df.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Breydo, L., Wu, J.W., Uversky, V.N., α-synuclein misfolding and Parkinson's disease (2012) Biochim. Biophys. Acta, 1822, pp. 261-285 
504 |a Lansbury, P.T., Lashuel, H.A., Review Article A century-old debate on protein aggregation and neurodegeneration enters the clinic (2006) Nature, 443, pp. 774-779 
504 |a Winner, B., In vivo demonstration that alpha-synuclein oligomers are toxic (2011) Proc. Natl. Acad. Sci. U.S.A., 108, pp. 4194-4199 
504 |a Steiner, J.A., Angot, E., Brundin, P., A deadly spread: Cellular mechanisms of α-synuclein transfer (2011) Cell Death Differ., 18, pp. 1425-1433 
504 |a Luk, K.C., Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice (2012) Science, 338, pp. 949-953 
504 |a Pornsuwan, S., Long-Range Distances in Amyloid Fibrils of α-Synuclein from PELDOR Spectroscopy (2013) Angew. Chem., , 10.1002/ange.201304747 
504 |a Fauerbach, J.A., Supramolecular non-amyloid intermediates in the early stages of α-synuclein aggregation (2012) Biophys. J., 102, pp. 1127-1136 
504 |a Roberti, M.J., Imaging nanometer-sized α-synuclein aggregates by superresolution fluorescence localization microscopy (2012) Biophys. J., 102, pp. 1598-1607 
504 |a Linse, S., Nucleation of protein fibrillation by nanoparticles (2007) Proc. Natl. Acad. Sci. U.S.A., 104, pp. 8691-8696 
504 |a Cabaleiro-Lago, C., Szczepankiewicz, O., Linse, S., The Effect of Nanoparticles on Amyloid Aggregation Depends on the Protein Stability and Intrinsic Aggregation Rate (2012) Langmuir, 28, pp. 1852-1857 
504 |a Cabaleiro-Lago, C., Quinlan-Pluck, F., Lynch, I., Dawson, K.A., Linse, S., Dual Effect of Amino Modified Polystyrene Nanoparticles on Amyloid β Protein Fibrillation (2010) ACS Chem. Neurosci., 1, pp. 279-287 
504 |a Cabaleiro-Lago, C., Inhibition of Amyloid Beta Protein Fibrillation by Polymeric Nanoparticles (2008) J. Am. Chem. Soc., 130, pp. 15437-15443 
504 |a Brambilla, D., PEGylated Nanoparticles Bind to and Alter Amyloid-Beta Peptide Conformation: Toward Engineering of Functional Nanomedicines for Alzheimer's Disease (2012) ACS Nano, 6, pp. 5897-5908 
504 |a Roberti, M.J., Quantum Dots as Ultrasensitive Nanoactuatorsand Sensors of Amyloid Aggregation in Live Cells (2009) J. Am. Chem. Soc., 131, pp. 8102-8107 
504 |a Roberti, M.J., Giordano, L., Jovin, T.M., Jares-Erijman, E.A., FRET imaging by k(t)/k(f) (2011) ChemPhysChem, 12, pp. 563-566 
504 |a Jain, P.K., Lee, K.S., El-Sayad, I.H., El-Sayed, M.A., Calculated Absorption and Scattering Properties of Gold Nanoparticles of Different Size, Shape, and Composition: Applications in Biological Imaging and Biomedicine (2006) J. Phys. Chem. B, 110, p. 7238 
504 |a Chithrani, B.D., Ghazani, A.A., Chan, W.C.W., Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells (2006) Nano Lett., 6, pp. 662-668 
504 |a Shukla, R., Biocompatibility of Gold Nanoparticles and Their Endocytotic Fate Inside the Cellular Compartment: A Microscopic Overview (2005) Langmuir, 21, pp. 10644-10654 
504 |a Sperling, R.A., Rivera Gil, P., Zhang, F., Zanella, M., Parak, W.J., Biological applications of gold nanoparticles (2008) Chem. Soc. Rev., 37, pp. 1896-1908 
504 |a Murphy, C.J., Gold nanoparticles in biology: Beyond toxicity to cellular imaging (2008) Acc. Chem. Res., 41, pp. 1721-1730 
504 |a Khlebtsov, N., Dykman, L., Biodistribution and toxicity of engineered gold nanoparticles: A review of in vitro and in vivo studies (2011) Chem. Soc. Rev., 40, pp. 1647-1671 
504 |a Yang, J.A., Study of Wild-Type α-Synuclein Binding and Orientation on Gold Nanoparticles (2013) Langmuir, 29, pp. 4603-4615 
504 |a Ai Tran, H.N., A novel class of potential prion drugs: Preliminary in vitro and in vivo data for multilayer coated gold nanoparticles (2010) Nanoscale, 2, pp. 2724-2732 
504 |a Bastus, N.G., Gold nanoparticles for selective and remote heating of β-amyloid protein aggregates (2007) Mater. Sci. Eng., C, 27, pp. 1236-1240 
504 |a Kogan, M.J., Nanoparticle-Mediated Local and Remote Manipulation of Protein Aggregation (2006) Nano Lett., 6, pp. 110-115 
504 |a Fink, A.L., The Aggregation and Fibrillation of alpha-Synuclein (2006) Acc. Chem. Res., 39, pp. 628-634 
504 |a Giehm, L., Lorenzen, N., Otzen, D.E., Assays for α-synuclein aggregation (2011) Methods, 53, pp. 295-305 
504 |a Kaylor, J., Characterization of Oligomeric Intermediates in a-Synuclein Fibrillation: FRET Studies of Y125W/Y133F/Y136F alpha-Synuclein (2005) J. Mol. Biol., 353, pp. 357-372 
504 |a Outeiro, T.F., Formation of toxic oligomeric alpha-synuclein species in living cells (2008) PLoS One, 3, p. 1867 
504 |a Morris, A.M., Finke, R.G., Alpha-synuclein aggregation variable temperature and variable pH kinetic data: A re-analysis using the Finke-Watzky 2-step model of nucleation and autocatalytic growth (2009) Biophys. Chem., 140, pp. 9-15 
504 |a Morris, A.M., Watzky, M.A., Finke, R.G., Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature (2009) Biochim. Biophys. Acta, 1794, pp. 375-397 
504 |a Lee, C.C., Nayak, A., Sethuraman, A., Belfort, G., McRae, G.J., A three-stage kinetic model of amyloid fibrillation (2007) Biophys. J., 92 (10), pp. 3448-3458 
504 |a Bertoncini, C.W., Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein (2005) Proc. Natl. Acad. Sci. U.S.A., 102, pp. 1430-1435 
504 |a Yushchenko, D.A., Fauerbach, J.A., Thirunavukkuarasu, S., Jares-Erijman, E.A., Jovin, T.M., Fluorescent Ratiometric MFC Probe Sensitive to Early Stages of Alpha-Synuclein Aggregation (2010) J. Am. Chem. Soc., 132, pp. 7860-7861 
504 |a Bertoncini, C.W., Celej, M.S., Small molecule fluorescent probes for the detection of amyloid self-assembly in vitro and in vivo (2011) Curr. Protein Pept. Sci., 12, pp. 205-220 
504 |a Groenning, M., Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status (2010) J. Chem. Biol., 3, pp. 1-18 
504 |a Coronado, E.A., Encina, E.R., Stefani, F.D., Optical properties of metallic nanoparticles: Manipulating light, heat and forces at the nanoscale (2011) Nanoscale, 3, pp. 4042-4059 
504 |a Morris, A.M., Watzky, M.A., Agar, J.N., Finke, R.G., Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: The Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth (2008) Biochemistry, 47, pp. 2413-2427 
504 |a Watzky, M.A., Morris, A.M., Ross, E.D., Finke, R.G., Fitting Yeast and Mammalian Prion Aggregation Kinetic Data with the Finke-Watzky Two-Step Model of Nucleation and Autocatalytic Growth (2008) Biochemistry, 47, pp. 10790-10800 
504 |a Vertegel, A.A., Siegel, R.W., Dordick, J.S., Silica Nanoparticle Size Influences the Structure and Enzymatic Activity of Adsorbed Lysozyme (2004) Langmuir, 20, pp. 6800-6807 
504 |a Shang, W., Nuffer, J.H., Dordick, J.S., Siegel, R.W., Unfolding of ribonuclease A on silica nanoparticle surfaces (2007) Nano Lett., 7, pp. 1991-1995 
504 |a Goy-López, S., Physicochemical Characteristics of Protein-NP Bioconjugates: The Role of Particle Curvature and Solution Conditions on Human Serum Albumin Conformation and Fibrillogenesis Inhibition (2012) Langmuir, 28, pp. 9113-9126 
504 |a Fei, L., Perrett, S., Effect of nanoparticles on protein folding and fibrillogenesis (2009) Int. J. Mol. Sci., 10, pp. 646-655 
504 |a Martin, M.N., Basham, J.I., Chando, P., Eah, S.-K., Charged Gold Nanoparticles in Non-Polar Solvents: 10-min Synthesis and 2D Self-Assembly (2010) Langmuir, 26, pp. 7410-7417 
504 |a Kimling, J., Turkevich Method for Gold Nanoparticle Synthesis Revisited (2006) J. Phys. Chem. B, 110, pp. 15700-15707 
520 3 |a α-synuclein (AS) is a small (140 amino acids), abundant presynaptic protein, which lacks a unique secondary structure in aqueous solution. Amyloid aggregates of AS in dopaminergic neurons of the midbrain are the hallmark of Parkinson's disease (PD). The process of aggregation involves a series of complex structural transitions from innocuous monomeric AS to oligomeric, presumably neurotoxic, forms and finally to fibril formation. Despite its potential importance for understanding PD pathobiology and devising rational, targeted therapeutic strategies, the details of the aggregation process remain largely unknown. Methodologies and reagents capable of controlling the aggregation kinetics are essential tools for the investigation of the molecular mechanisms of amyloid diseases. In this work, we investigated the influence of citrate-capped gold nanoparticles on the aggregation kinetics of AS using a fluorescent probe (MFC) sensitive to the polarity of the molecular microenvironment via excited state intramolecular proton transfer (ESIPT). The particular effects on the half time, nucleation time, and growth rate were ascertained. Gold nanoparticles produced a strong acceleration of protein aggregation with an influence on both the nucleation and growth phases of the overall mechanism. The effects were dependent on the size and concentration of the nanoparticles, being strongest for nanoparticles 10 nm in diameter, which produced a 3-fold increase in the overall aggregation rate at concentrations as low as 20 nM. © 2013 American Chemical Society.  |l eng 
593 |a Departamento de Física, Facultad de Ciencias Exactas y Naturales (FCEN), Universidad de Buenos Aires (UBA), Buenos Aires, Argentina 
593 |a Instituto de Física de Buenos Aires (IFIBA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina 
593 |a Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales (FCEN), Universidad de Buenos Aires (UBA), Buenos Aires, Argentina 
593 |a Centro de Investigación en Hidratos de Carbono (CIHIDECAR), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina 
593 |a Laboratory for Cellular Dynamics, Max Planck Institute for Biophysical Chemistry, Goettingen, Germany 
690 1 0 |a AMYLOID AGGREGATION 
690 1 0 |a AMYLOID PROTEINS 
690 1 0 |a GOLD NANOPARTICLES 
690 1 0 |a PARKINSON 
690 1 0 |a AGGREGATION KINETICS 
690 1 0 |a AMYLOID PROTEINS 
690 1 0 |a EXCITED-STATE INTRAMOLECULAR PROTON TRANSFER 
690 1 0 |a GOLD NANOPARTICLES 
690 1 0 |a NUCLEATION AND GROWTH 
690 1 0 |a PARKINSON 
690 1 0 |a SECONDARY STRUCTURES 
690 1 0 |a STRUCTURAL TRANSITIONS 
690 1 0 |a AGGLOMERATION 
690 1 0 |a AMINO ACIDS 
690 1 0 |a GLYCOPROTEINS 
690 1 0 |a GOLD 
690 1 0 |a KINETICS 
690 1 0 |a METAL NANOPARTICLES 
690 1 0 |a NEURONS 
690 1 0 |a PROTEINS 
690 1 0 |a ALPHA SYNUCLEIN 
690 1 0 |a AMYLOID 
690 1 0 |a GOLD 
690 1 0 |a METAL NANOPARTICLE 
690 1 0 |a ARTICLE 
690 1 0 |a CHEMISTRY 
690 1 0 |a HUMAN 
690 1 0 |a KINETICS 
690 1 0 |a PARKINSON DISEASE 
690 1 0 |a PATHOLOGY 
690 1 0 |a PROTEIN SECONDARY STRUCTURE 
690 1 0 |a ALPHA-SYNUCLEIN 
690 1 0 |a AMYLOID 
690 1 0 |a GOLD 
690 1 0 |a HUMANS 
690 1 0 |a KINETICS 
690 1 0 |a METAL NANOPARTICLES 
690 1 0 |a PARKINSON DISEASE 
690 1 0 |a PROTEIN STRUCTURE, SECONDARY 
700 1 |a Fauerbach, J.A. 
700 1 |a Pellegrotti, J.V. 
700 1 |a Jovin, T.M. 
700 1 |a Jares-Erijman, E.A. 
700 1 |a Stefani, F.D. 
773 0 |d 2013  |g v. 13  |h pp. 6156-6163  |k n. 12  |p Nano Lett.  |x 15306984  |t Nano Letters 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890413185&doi=10.1021%2fnl403490e&partnerID=40&md5=eaba1caccc617bf7b2e8c62e07231024  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1021/nl403490e  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_15306984_v13_n12_p6156_Alvarez  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_15306984_v13_n12_p6156_Alvarez  |y Registro en la Biblioteca Digital 
961 |a paper_15306984_v13_n12_p6156_Alvarez  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 72012